Insiders

12-01 Altimmune, Inc. Announces CEO Changes CI
12-01 Altimmune, Inc. Announces Executive Changes CI
12-01 Altimmune CEO Vipin Garg to Step Down MT
12-01 Altimmune announces CEO transition, succession plan RE
11-10 Celldex Therapeutics, Inc. Announces Executive Changes CI
11-06 Altimmune, Inc. Announces Appointment of Robin Abrams, J.D., as Chief Legal Officer CI
25-09-29 Altimmune, Inc. Announces the Appointment of Christophe Arbet-Engels as Chief Medical Officer, Effective October 1, 2025 CI
25-09-15 Altimmune, Inc. Appoints Linda M. Richardson to the Role of Chief Commercial Officer, Effective September 16, 2025 CI
25-09-15 Altimmune appoints Linda M. Richardson as Chief Commercial Officer RE
25-08-11 Altimmune Names Jerry Durso Chair MT
25-08-11 Altimmune Appoints Jerry Durso as Chairman, Effective August 12, 2025 CI
25-02-27 Altimmune, Inc. Announces Retirement of Scott Harris as Chief Medical Officer, Effective February 28, 2026 CI
25-02-25 Altimmune, Inc. Announces Board Appointments CI
24-11-11 Altimmune Names Greg Weaver Chief Financial Officer MT
24-08-15 Altimmune, Inc. Announces That David J. Drutz Will Not Stand for Re-Election to the Board CI
24-06-26 Altimmune CFO Richard Eisenstadt Dies MT
24-06-26 Altimmune, Inc. Appoints Andrew Shutterly as Principal Financial Officer and Principal Accounting Officer CI
23-03-27 Altimmune, Inc. Appoints Catherine Angell Sohn, Pharm.D. to Its Board of Directors CI
23-01-04 Altimmune, Inc. Appoints Raymond Jordt as Chief Business Officer CI
22-12-22 Insider Sell: Altimmune MT
22-09-01 Insider Sell: Altimmune MT
22-07-05 Insider Sell: Altimmune MT
22-06-28 Insider Sell: Altimmune MT
21-12-13 Altimmune, Inc. Announces Management Changes CI
21-12-13 Altimmune Names Richard Eisenstadt as Next CFO MT
No results for this search